Current Report Filing (8-k)
December 08 2021 - 04:29PM
Edgar (US Regulatory)
0000867028 false 0000867028 2021-11-28
2021-11-28 iso4217:USD xbrli:shares iso4217:USD xbrli:shares
UNITED
STATES
SECURITIES AND
EXCHANGE COMMISSION
Washington, DC
20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the
Securities Exchange
Act of 1934
Date of
Report (Date of earliest event reported):
November 28, 2021
FOMO CORP.
(Exact
name of Registrant as specified in its Charter)
|
california |
|
001-13126 |
|
83-3889101 |
|
(State or
other jurisdiction
of
incorporation)
|
|
(Commission
File
No.)
|
|
(IRS
Employer
Identification
No.)
|
1 E Erie St,
Ste 525 Unit #2250,
Chicago,
IL
60611
(Address of
principal executive offices)
(630)
286-9560
(Registrant’s Telephone
Number)
(Former name
or address, if changed since last report)
Check the
appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant
under any of the following provisions (see General Instruction A.2.
below):
|
☐ |
Written
communications pursuant to Rule 425 under the Securities Act (17
CFR 230.425) |
| |
|
|
☐ |
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12) |
| |
|
|
☐ |
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17
CFR 240.14d-2(b)) |
| |
|
|
☐ |
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17
CFR 240.13e-4(c)) |
Securities
registered pursuant to Section 12(b) of the Act:
|
Title of
each class |
|
Trading
symbol(s) |
|
Name of each
exchange on which registered |
|
Common |
|
FOMC |
|
OTC
Pink |
Indicate by
check mark whether the registrant is an emerging growth company as
defined in Rule 405 of the Securities Act of 1933 (17 CFR 230.405)
or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR
240.12b-2)
☒
If an
emerging growth company, indicate by check mark if the registrant
has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided
pursuant to Section 13(a) of the Exchange Act
FOMO CORP.
is referred to herein as “FOMO”, “the Company”, “we”, or
“us”.
Item 8.01
Other Items.
On November
28, 2021, Himalaya Technologies, Inc. a/k/a Homeland Resources Ltd.
(OTC: HMLA; https://www.himalayatechnologies.com/),
a minority-owned subsidiary of FOMO (https://www.fomoworldwide.com/),
purchased 13,883,812 shares of GenBio, Inc. (“GenBio”; https://genbioinc.com/) common
stock using consideration of 99,686 Himalaya Series B preferred
shares, representing 19.9% ownership of GenBio. The Companies
intend to collaborate on nutraceutical products offering
anti-inflammatory and reduced blood pressure applications including
powders, enhanced honey extracts, droplets and canned beverages
under the brands “FOMO” and others.
Item 9.01. Exhibits
(a)
Exhibits. The following exhibits are filed with this Current Report
on Form 8-K:
SIGNATURES
Pursuant to
the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.
| |
FOMO
CORP. |
| |
|
|
Date:
December 8, 2021 |
By: |
/s/
Vikram Grover |
| |
|
Vikram
Grover |
| |
|
Chief Executive
Officer |
FOMO (PK) (USOTC:FOMC)
Historical Stock Chart
From Apr 2022 to May 2022
FOMO (PK) (USOTC:FOMC)
Historical Stock Chart
From May 2021 to May 2022
